Bharat Immunologicals & Biologicals Corporation has informed that a meeting of the Board of Directors of the Company is scheduled to be held on January 23, 2017, to approve and take on record the Un-audited Quarterly/Nine months Financial Results of the Company for the quarter/period ended December 31, 2016.
The above information is a part of company’s filings submitted to BSE.